News
Dominica Prioritises Strengthening Healthcare Infrastructure with Citizenship-by-Investment Funds

LONDON, Jan. 28, 2021 /PRNewswire/ — The Commonwealth of Dominica is building twelve new health centres as part of a broader mission to strengthen its healthcare infrastructure and provide citizens with higher quality services. Construction on the Bagatelle Health Centre is the latest to be nearing completion after the government invested $2 million into the project utilising funds from its Citizenship by Investment (CBI) Programme.
Aside from commissioning several new health centres, Dominica is also in the process of constructing a state-of-the-art hospital, scheduled to be completed in April 2021, also funded by the CBI Programme. The Programme previously sponsored the repair of several hospitals and health facilities following a hurricane in 2017 and supported the overseas medical treatment of 16 children.
Prime Minister Dr the Hon. Roosevelt Skerrit highlighted this commitment to grow the island's healthcare offering: “This can also be translated into better care for our citizens and residents. There will be no complaints about the quality of services or the quality of equipment. I am happy about this investment here, and we will have a series of openings for such facilities in Dominica in just a few weeks.”
With the COVID-19 pandemic reiterating the importance of having a robust health care system in place, Dominica remains one of the least impacted by the virus. A recent report from 4,000 scientists ranked the island as one of the few in the “green zone”, meaning Dominica is tackling the virus well and has recorded no local transmissions for over 14 days.
Established in 1993, Dominica's CBI Programme has been fundamental to the future of the island's healthcare services. The Programme enables foreign investors and their families to become citizens of the nation once investing in either a government fund or buying into selected real estate options. Once all due diligence checks are passed, successful applicants gain visa-free access to over 140 destinations, the right to live and work in the country and the ability to pass down citizenship down for generations to come.
Investments generated under the Programme are injected into important sectors in Dominica, from healthcare and education to tourism and infrastructure development. The Programme also supports the construction of over 5,000 climate-resilient homes for citizens impacted by Hurricane Maria. Dominica is a progressive and safe country for investors who choose to reside there with a burgeoning healthcare system that is anticipated to be one of the strongest in the Caribbean.
[email protected], www.csglobalpartners.com
News
AMYRIS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amyris, Inc. – AMRS

NEW ORLEANS, Feb. 26, 2021 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Amyris, Inc. (NasdaqGS: AMRS).
On November 13, 2018, the Company reported poor financial results for third quarter 2018, with $14.9 million revenue compared to $22.5 million revenue in the prior year period, and attributed the performance to the “volatility of the Vitamin E market.”
On March 19, 2019, the Company disclosed that its 2018 annual report would not be filed timely due to “significant time and resources that were devoted to the accounting for and disclosure of the significant transactions with Koninklijke DSM N.V. that closed in November 2018” and that it “is in the process of completing its evaluation of internal control over financial reporting and may have further deficiencies to report.”
Finally, on April 11, 2019, the Company announced that it was restating its fiscal 2018 results to reduce revenue by at least $12 million and increase net loss by at least $7 million, explaining, among other things, that “a material error was made related to the estimates for recognizing revenue for royalty payments” and that it “expects to report material weaknesses in addition to the material weakness reported in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017.”
The Company has been sued in a securities class action lawsuit for failing to disclose material information, violating federal securities laws. Recently, the court in that case denied the Company's motion to dismiss, allowing the case to move forward.
KSF's investigation is focusing on whether Amyris' officers and/or directors breached their fiduciary duties to Amyris' shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of Amyris shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-amrs/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163
View original content to download multimedia:http://www.prnewswire.com/news-releases/amyris-investigation-initiated-by-former-louisiana-attorney-general–kahn-swick–foti-llc-investigates-the-officers-and-directors-of-amyris-inc—amrs-301236794.html
SOURCE Kahn Swick & Foti, LLC
News
BIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN

NEW ORLEANS, Feb. 26, 2021 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN).
On August 19, 2020, the Company disclosed that it received a Complete Response Letter (“CRL”) from the FDA rejecting its Biologics License Application (“BLA”) for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company's ongoing 270-301 study (Phase 3) and that the Company “complete the Phase 3 Study and submit two-year follow-up safety and efficacy data on all study participants,” thus requiring a lengthier study before approval would be considered.
Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing.
KSF's investigation is focusing on whether BioMarin's officers and/or directors breached their fiduciary duties to BioMarin's shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of BioMarin shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-bmrn/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163
View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-investigation-initiated-by-former-louisiana-attorney-general–kahn-swick–foti-llc-investigates-the-officers-and-directors-of-biomarin-pharmaceutical-inc—bmrn-301236793.html
SOURCE Kahn Swick & Foti, LLC
News
TIVITY HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tivity Health, Inc. – TVTY

NEW ORLEANS, Feb. 26, 2021 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Tivity Health, Inc. (NasdaqGS: TVTY).
On February 19, 2020, the Company announced its financial results for the fourth quarter and year ended December 31, 2019, disclosing that its “Nutrition segment had a disappointing end to 2019” including “a non-cash impairment charge of $377.1 million,” that contributed to a $272.8 million net loss in the fourth quarter, due to complications in the nutrition business since its acquisition of Nutrisystem in March 2019, and also that its Chief Executive Officer had resigned. In September of 2020, the Company announced the resignation of co-founder Daniel G. Tully from its Board of Directors. Then, in October of 2020, it was reported that the Company would be selling Nutrisystem for $575 million, less than half of what Tivity paid to buy it.
The Company and certain of its executives have been sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing.
KSF's investigation is focusing on whether Tivity's officers and/or directors breached their fiduciary duties to Tivity's shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of Tivity shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-tvty/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163
View original content to download multimedia:http://www.prnewswire.com/news-releases/tivity-health-investigation-initiated-by-former-louisiana-attorney-general–kahn-swick–foti-llc-investigates-the-officers-and-directors-of-tivity-health-inc—tvty-301236792.html
SOURCE Kahn Swick & Foti, LLC